StockNews.com initiated coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a research note issued to investors on Thursday. The firm issued a buy rating on the biopharmaceutical company’s stock. Vanda Pharmaceuticals Trading Up 0.2 % NASDAQ:VNDA opened at $5.85 on Thursday. Vanda Pharmaceuticals has a 1 year low of $5.45 and a […]
Vanda Pharmaceuticals (NASDAQ:VNDA) Receives New Coverage from Analysts at StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Los Angeles Capital Management LLC raised its holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 248.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 238,125 shares of the biopharmaceutical company’s stock after buying an additional 169,768 shares during the quarter. Los […]
Vanda Pharmaceuticals (NASDAQ:VNDA) Downgraded to Buy at StockNews com kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report) will be posting its quarterly earnings results after the market closes on Thursday, July 27th. Analysts expect Vanda Pharmaceuticals to post earnings of ($0.13) per share for the quarter. Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report) last issued its earnings results on Wednesday, May 3rd. The biopharmaceutical company […]